MAP Pharmaceuticals, Inc.

• About Us 
  • Message from the CEO
  • Management Team
  • Board of Directors
  • Partnering
  • Contact Us
• Product Pipeline 
  • Migraine
  • Pediatric Asthma
  • Asthma/COPD
  • Diabetes
• Investor Relations 
  • IR Home
  • Press Releases
  • Events and Presentations
  • Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Annual Reports
  • SEC Filings
  • Stock Information
  • Analyst Coverage
  • Contact Us
• Science & Technology 
• Publications 
  • Migraine
  • Asthma
  • Aerosol Science & Technology

Investor Relations

Print page     Email page

SEC Filings

View: All Filings Annual Quarterly Current Section 16 Proxy Other    Year: All Years 2010 2009 2008 2007

Filing	Description	Date Filed	Size
CERTNAS	national exchange activity	Oct 5, 2007	0.0 KB
EFFECT	effectiveness order	May 5, 2009	0.0 KB
EFFECT	effectiveness order	Oct 4, 2007	0.0 KB
3	elms steve	Oct 4, 2007	20.8 KB
3	wolff henry ward	Mar 25, 2008	20.8 KB
3	ward scott r	Sep 26, 2008	16.0 KB
3	kellerman donald j	Jul 25, 2008	16.3 KB
3	kelley bernard j	Oct 4, 2007	22.2 KB
4	elms, steve	Feb 24, 2010	19.2 KB
3	friedman charlene a	Oct 4, 2007	22.5 KB
5	gianakakos anastasios	Jan 22, 2010	19.5 KB
4	gianakakos, anastasios	May 19, 2008	24.4 KB
4	elms, steve	Mar 12, 2010	19.4 KB
5	nelson timothy s	Jan 20, 2009	19.5 KB
4	nelson, timothy s	Mar 9, 2009	19.4 KB
4	elms, steve	Feb 16, 2010	19.6 KB
3	firstmark capital, l.l.c.	Aug 25, 2008	18.1 KB
5	armer thomas a	Jan 22, 2010	20.1 KB
4	kelley, bernard j	May 22, 2009	19.9 KB
4	kelley, bernard j	May 21, 2010	19.9 KB
Showing 1-20 of 284 Page: 1 2 3 ... 15  Next 20

= add filing to Briefcase

Stock Information

NASDAQ:MAPP $12.78	- 0.02
Sep 10, 2010	11:23 AM ET

Quotes delayed at least 20 minutes.
Information provided by eSignal.